EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute pancreatitis induced by Daratumumab during multiple myeloma maintenance

Abel Trujillano Ruiz iD, María de Los Remedios Arcas Vega, Juan Sebastián González, María Del Mar Romero Gonzalez

Journal of Oncology Pharmacy Practice · 23.07.2026

DOI: 10.1177/10781552261471787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 23.07.2026. Verfasst von Abel Trujillano Ruiz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Hospital Universitario de La Línea de la Concepción, Cádiz, Spain. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute pancreatitis is a potential but rare adverse drug reaction. We report a delayed-onset case induced by daratumumab during multiple myeloma maintenance. Case Report A 60-year-old non-smoking male under maintenance therapy with daratumumab, lenalidomide, and dexamethasone presented with sudden-onset acute abdominal pain and severe enzymatic elevation (amylase >40x ULN). Biliary and metabolic etiologies, as well as lenalidomide triggers, were thoroughly ruled out. Management & Outcome Discontinuation of daratumumab and conservative management led to complete clinical and biochemical recovery. A Naranjo algorithm score of 5 indicated a probable causal relationship.

Discussion

CD38 inhibition may alter intracellular calcium homeostasis in pancreatic tissue, prompting long-term proactive pharmacovigilance in onco-hematology units even during late maintenance phases.

Schlagwörter

Stichwörter der Autor:innen

Daratumumabadverse drug reactiondrug-induced pancreatitismultiple myelomapharmacovigilance

Autor:innen und Institutionen

  • Department of Hospital Pharmacy, Hospital Universitario de La Línea de la Concepción, Cádiz, Spain.
  • Department of Hematology and Hemotherapy, Hospital Universitario de La Línea de la Concepción, Cádiz, Spain.

ORCID-Profile: Abel Trujillano Ruiz

Zitieren

APA

Trujillano Ruiz, A., Arcas Vega, M. L. R., González, J. S., & Romero Gonzalez, M. D. M. (2026). Acute pancreatitis induced by Daratumumab during multiple myeloma maintenance. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261471787

Vancouver

Trujillano Ruiz A, Arcas Vega MLR, González JS, Romero Gonzalez MDM. Acute pancreatitis induced by Daratumumab during multiple myeloma maintenance. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261471787

BibTeX
@article{TrujillanoRuiz2026,
  author = {Trujillano Ruiz, Abel and Arcas Vega, María de Los Remedios and González, Juan Sebastián and Romero Gonzalez, María Del Mar},
  title = {Acute pancreatitis induced by Daratumumab during multiple myeloma maintenance},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2026},
  doi = {10.1177/10781552261471787}
}
Kostenlos starten →